[HTML][HTML] Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin

A Lakshmanan, D Scarberry, JA Green, X Zhang… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Targeted radioiodine therapy for thyroid cancer is based on selective stimulation of Na+/I−
Symporter (NIS)-mediated radioactive iodide uptake (RAIU) in thyroid cells by thyrotropin …

Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin

A Lakshmanan, D Scarberry, JA Green, X Zhang… - Oncotarget, 2015 - hero.epa.gov
Targeted radioiodine therapy for thyroid cancer is based on selective stimulation of Na+/I-
Symporter (NIS)-mediated radioactive iodide uptake (RAIU) in thyroid cells by thyrotropin …

Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin.

A Lakshmanan, D Scarberry, JA Green, X Zhang… - Oncotarget, 2015 - europepmc.org
Targeted radioiodine therapy for thyroid cancer is based on selective stimulation of Na+/I−
Symporter (NIS)-mediated radioactive iodide uptake (RAIU) in thyroid cells by thyrotropin …

Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin

A Lakshmanan, D Scarberry, JA Green… - …, 2015 - pubmed.ncbi.nlm.nih.gov
Targeted radioiodine therapy for thyroid cancer is based on selective stimulation of Na+/I-
Symporter (NIS)-mediated radioactive iodide uptake (RAIU) in thyroid cells by thyrotropin …

[PDF][PDF] Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin

A Lakshmanan, D Scarberry, JA Green, X Zhang… - researchgate.net
Targeted radioiodine therapy for thyroid cancer is based on selective stimulation of Na+/I-
Symporter (NIS)-mediated radioactive iodide uptake (RAIU) in thyroid cells by thyrotropin …

[PDF][PDF] Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin

A Lakshmanan, D Scarberry, JA Green, X Zhang… - pdfs.semanticscholar.org
Targeted radioiodine therapy for thyroid cancer is based on selective stimulation of Na+/I-
Symporter (NIS)-mediated radioactive iodide uptake (RAIU) in thyroid cells by thyrotropin …

[HTML][HTML] Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin

A Lakshmanan, D Scarberry, JA Green, X Zhang… - Oncotarget, 2015 - oncotarget.com
Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin |
Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial Board Submission …

Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin

A Lakshmanan, D Scarberry, JA Green… - …, 2015 - ohiostate.elsevierpure.com
Targeted radioiodine therapy for thyroid cancer is based on selective stimulation of Na+/I-
Symporter (NIS)-mediated radioactive iodide uptake (RAIU) in thyroid cells by thyrotropin …

Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin.

A Lakshmanan, D Scarberry, JA Green, X Zhang… - Oncotarget, 2015 - europepmc.org
Targeted radioiodine therapy for thyroid cancer is based on selective stimulation of Na+/I−
Symporter (NIS)-mediated radioactive iodide uptake (RAIU) in thyroid cells by thyrotropin …

[PDF][PDF] Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin

A Lakshmanan, D Scarberry, JA Green, X Zhang… - researchgate.net
Targeted radioiodine therapy for thyroid cancer is based on selective stimulation of Na+/I-
Symporter (NIS)-mediated radioactive iodide uptake (RAIU) in thyroid cells by thyrotropin …